DOCSLIB.ORG

7 Príloha Č. 1 K Tretej Hlave Druhej Časti Potravinového Kódexu

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
7 Príloha Č. 1 K Tretej Hlave Druhej Časti Potravinového Kódexu Príloha č. 1 k tretej hlave druhej časti potravinového kódexu Kontaminanty v potravinách Časť A Chemické prvky 1. Chemické prvky v potravinách sú prvky, ktoré sa dostávajú do potravín z pôdy, vody a z ovzdušia ako kontaminanty; niektoré z nich môžu byť aj prirodzenou zložkou potravín. Pri posudzovaní ich zisteného množstva v potravinách nie je rozhodujúci spôsob, akým sa do potravín dostali a či sa vyskytujú v čistej forme alebo v zlúčeninách. Na posudzovanie rádionuklidov v potravinách sa vzťahujú osobitné požiadavky podľa šiestej hlavy druhej časti potravinového kódexu. 2. Najvyššie prípustné množstvo chemických prvkov vo výrobkoch na dojčenskú a detskú výživu sa vzťahuje na ich konzumnú formu podľa ich odporúčaného najmenšieho zriedenia. 3. Ak sú ryby určené celé na konzum, najvyššie prípustné množstvo sa vzťahuje na celé ryby. Chemický Najvyššie prípustné Potravina prvok množstvo v mg.kg-1 Arzén 0,05 mlieko, potraviny pre dojčatá a malé deti na báze mlieka 0,1 mäso a mäsové výrobky, múka, vajcia a výrob- ky z vajec, rastlinné tuky a oleje a živočíšne tuky, potraviny pre dojčatá a malé deti na ovocnom a zeleninovom základe 0,2 zverina a výrobky z nej, obilie a výrobky z neho, ocot, nápoje vrátane nápojov z ovocia a zeleniny, výrobky z mlieka okrem tvrdých syrov 0,3 zemiaky 0,5 tvrdé syry, ovocie a zelenina a výrobky z nich, strukoviny, čerstvé huby, čokoláda a výrobky z čo- kolády 1,0 vnútornosti a výrobky z nich, ryby sladkovodné a výrobky z nich, cukor a ostatné prírodné sladidlá okrem práškového cukru, cukrovinky, kakaový prášok a kakaové zmesi, čaj na prípravu nápoja, kávové výťažky 2,0 droždie pekárske, ovsené vločky a výrobky z nich, želatína, práškový cukor 3,0 výživové doplnky, pochutiny, med, dehydrované a instantné potraviny 5,0 ryby morské a výrobky z nich, koreniny 8,0 mäkkýše, kôrovce 1,0 ostatné potraviny Cín 25,0 potraviny pre dojčatá a malé deti na báze ovocia a zeleniny 100,0 zahustené mlieko v kovových obaloch 150,0 jablčné a hroznové šťavy a šťavy z čiernych ríbezlí vrátane nektárov z bobuľového ovocia 250,0 výrobky z ovocia a zeleniny v kovových obaloch 100,0 ostatné potraviny 7 Chemický Najvyššie prípustné Potravina prvok množstvo v mg.kg-1 Hliník 1,0 mlieko a výrobky z neho, potraviny pre dojčatá a malé deti 5,0 nápoje 10,0 mäso, ovocné šťavy, víno 100,0 ostatné potraviny Chróm 0,05 potraviny pre dojčatá a malé deti na báze mlieka 0,1 mlieko 0,5 výrobky z mlieka 1,0 nápoje 4,0 ostatné potraviny Kadmium 0,05 mäso hovädzie, ovčie, bravčové, hydinové okrem vedľajších jatočných produktov 0,2 konské mäso 0,5 pečeň hovädzieho dobytka, oviec, ošípaných a hy- diny 1,0 obličky hovädzieho dobytka, oviec, ošípaných a hy- diny 0,05 mäso zo svalov rýb okrem rýb ďalej uvedených 0,1 mäso zo svalov: pelamídy atlantickej (Sarda sar- da), morana obyčajného (Diplodus vulgaris), úho- ra (Anguilla anguilla), ančovičky európskej (En- graulis encrasicholus), parmice šedej (Mugil la- brosus labrosus), stavridy alebo kranasa (Tra- churus trachurus), luvara (Luvarus imperialis), pil- charda alebo sardinky európskej (Sardina pilchar- dus), sardiniek z rodu Sardinops (Sardinops spe- cies), tuniakov (Thunnus a Euthynnus species), morského jazyka (Dicologoglossa cuneata) 0,5 kôrovce okrem hnedého mäsa kraba a mäsa z hlavy a hrude homára a podobných veľkých kô- rovcov (z čeľadí Nephropidae a Palinuridae) 1,0 lastúrniky, hlavonožce bez vnútorností 0,1 obilie okrem zrna pšenice, otrúb, klíčkov a ryže 0,2 zrno pšenice, otruby, klíčky a ryža, sójové bôby 0,05 zelenina a ovocie okrem listovej zeleniny, čer- stvých bylín, všetkých húb, hlúbovej zeleniny, ko- reňovej zeleniny a zemiakov 0,2 listová zelenina, čerstvé byliny, zeler a pestované huby 0,1 hlúbová a koreňová zelenina okrem zeleru, ze- miaky 0,005 potraviny pre dojčatá a malé deti na báze mlieka 0,01 mlieko, pivo 0,02 vajcia a výrobky z vajec, cukor 0,03 potraviny pre dojčatá a malé deti na ovocnej a zeleninovej báze 0,05 výrobky z mlieka, nealkoholické nápoje 0,06 tvrdé syry 0,1 zverina 8 Chemický Najvyššie prípustné Potravina prvok množstvo v mg.kg-1 0,5 kakaový prášok, čokoláda, výživové doplnky, po- chutiny, med, dehydrované a instantné potraviny 0,8 mak 1,0 voľne rastúce čerstvé huby, čaj na prípravu ná- poja, želatína 0,1 ostatné potraviny Meď 0,1 rastlinné oleje okrem panenských 0,4 rastlinné oleje panenské, tuky, mlieko 0,8 potraviny pre dojčatá a malé deti na báze mlieka 1,0 cukor 2,5 výrobky z mlieka okrem tvrdých syrov 3,0 zemiaky, vajcia a výrobky z vajec 5,0 potraviny pre dojčatá a malé deti na báze obilia alebo na báze ovocia a zeleniny, mäso a mäsové výrobky, zverina a výrobky z nej, múka, nealko- holické nápoje, víno, pivo, glukózový sirup 10,0 ryby a výrobky z nich, výrobky z obilia, zelenina a výrobky z nej, voľne rastúce čerstvé huby, ze- miakový škrob 15,0 cukrovinky, strukoviny 20,0 tvrdé syry 25,0 rajčinový pretlak 30,0 želatína, mäkkýše, kôrovce, čokoláda a výrobky z čokolády, káva, hrozienka, ostatné alkoholické nápoje 50,0 kakaový prášok a kakaové zmesi 80,0 vnútornosti a výrobky z nich 150,0 čaj na prípravu nápoja 25,0 ostatné potraviny Nikel 0,1 potraviny pre dojčatá a malé deti na báze mlieka, mlieko, rastlinné oleje 0,4 potraviny pre dojčatá a malé deti na báze ovocia, obilia a zeleniny 0,5 mäso a mäsové výrobky, ryby, ovocie a výrobky z nich, zemiaky 2,5 zelenina 3,0 stužené tuky a margaríny, výrobky z obilia 5,0 čokoláda a čokoládové výrobky 6,0 strukoviny, výživové doplnky, pochutiny, med, de- hydrované a instantné potraviny 10,0 orechy, sója a výrobky z nej 2,0 ostatné potraviny Olovo 0,02 kravské mlieko (surové mlieko, mlieko na výrobu mliečnych výrobkov a tepelne ošetrené mlieko) 0,02 potraviny pre dojčatá a malé deti na báze mlieka 0,1 mäso hovädzie, ovčie, bravčové a hydinové 0,5 vnútornosti hovädzie, ovčie, bravčové a hydinové 0,2 mäso zo svalov rýb okrem rýb ďalej uvedených 9 Chemický Najvyššie prípustné Potravina prvok množstvo v mg.kg-1 0,4 mäso zo svalov: pelamídy atlantickej (Sarda sarda), morana obyčajného (Diplodus vulgaris), úhora (Anguilla anguilla), parmice šedej (Mugil labrosus labrosus), grunta (Pomodasys benneti), stavridy alebo kranasa (Trachurus trachurus), pilcharda alebo sardinky európskej (Sardina pilchardus), sardiniek z rodu Sardinops (Sar- dinops species), morského okúňa škvrnitého (Di- centrarchus punctatus), tuniakov (Thunnus a Euthynnus species), morského jazyka (Dicolo- goglossa cuneata) 0,5 kôrovce okrem hnedého mäsa kraba 1,0 hlavonožce (bez vnútorností) 1,5 lastúrniky 0,2 obilie vrátane pohánky, strukoviny 0,1 zemiaky, zelenina okrem brokolice, listovej ze- leniny, čerstvých bylín a všetkých húb 0,3 brokolica, listová zelenina a všetky pestované huby 0,1 ovocie všeobecne okrem bobúľ a drobného ovocia 0,2 bobule a drobné ovocie 0,1 tuky a oleje vrátane mliečneho tuku 0,05 ovocné šťavy, koncentrované ovocné šťavy ur- čené na priamu spotrebu, ovocné nektáre 0,2 vína vrátane šumivých okrem likérových vín, aro- matizované vína, aromatizované nápoje na báze vín, jablčná a hrušková šťava, ovocné vína 0,02 nealkoholické nápoje, pivo 0,1 potraviny pre dojčatá a malé deti na báze ovocia a zeleniny, vajcia a výrobky z vajec 0,3 mliečne výrobky 0,5 mäkké syry 0,7 tvrdé syry, ryža 1,0 voľne rastúce čerstvé huby 2,0 kakaový prášok, práškový cukor, glukózový sirup 3,0 hrozienka 5,0 čaj na prípravu nápoja, želatína, výživové doplnky, pochutiny, med, dehydrované a instatné potraviny 1,0 ostatné potraviny Ortuť 0,5 rybie výrobky okrem výrobkov z rýb ďalej uve- dených 1,0 čert morský (Lophius species), sumec atlantický (Anarhichas lupus), okúň lavrak (Dicentrarchus labrax), mieň modrý (Molva dipterygia), pelamída atlantická (Sarda sarda), úhor (Anguilla species), Hoplostethus atlanticus, Coryphaenoides rupestris, halibut (Hippoglossus hippoglossus), marlin (Makaira species), šťuka (Esox lucius), 10 Chemický Najvyššie prípustné Potravina prvok množstvo v mg.kg-1 pelamída jednofarebná (Orcynopsis unicolor), žralok portugalský (Centroscymnes coelolepis), raje (Raja species), sebastesy alebo morské ostrieže (Sebaste marinius, S. mentella, S. vivi- parus), plachetník obyčajný (Istiophorus platy- pterus), šupinoplutvovec (Lepidopus caudatus, Aphanopus carbo), žralok (všetky druhy), makrela hadia (Lepidocybium flavobrunneum,Ruvettus pretiosus, Gempylus serpens), jeseter (Acipenser species), mečiar obyčajný (Xiphias gladius), tuniaky (Thunnus a Euthynnus species) 0,003 potraviny pre dojčatá a malé deti na báze mlieka 0,01 mlieko, potraviny pre dojčatá a malé deti na bá- ze ovocia a zeleniny 0,02 mliečne výrobky, zemiaky 0,03 vajcia a výrobky z vajec, ovocie 0,05 mäso a mäsové výrobky 0,05 SL: 0,03 zelenina 0,5 mäkkýše, kôrovce, výživové doplnky, pochutiny, med, dehydrované a instantné potraviny 0,75 SL: 0,25 čerstvé huby 0,1 vnútornosti 0,05 ostatné potraviny 11 Časť B Dusičnany 1. Dusičnany sú soli kyseliny dusičnej, ktoré sa do potravín dostávajú ako kontaminanty prevažne z pôdy a vody. 2. Najvyššie prípustné množstvo pre čerstvý špenát sa nevzťahuje na čerstvý špenát určený na spracovanie, ktorý sa priamo dopravuje z poľa do spracovateľského závodu. 3. Ak nie je k dispozícii údaj o spôsobe pestovania hlávkového šalátu, platí hodnota určená pre hlávkový šalát pestovaný vonku. - 4. Minimálny počet vzoriek na laboratórne vyšetrenie je 10. Výsledky sa vyjadrujú na dusičnanový ión NO3 . 5. Najvyššie prípustné množstvá pre hlávkový šalát a špenát sa prehodnocujú v EÚ do r. 2005. Tabuľka č. 2 Najvyššie prípustné Potravina množstvo v mg.kg-1 --- (ako NO3 ) čerstvý špenát (Spinacia Oleracea) zo zberu 3 000 - od 1.XI. do 31. III. 2 500 - od 1.IV. do 31. X. 2 000 špenát sterilizovaný, hlboko zmrazený alebo mrazený čerstvý hlávkový šalát (Lactuca sativa L.) zo zberu (okrem typu „iceberg“) 4 500 - od 1. X. do 31.III.- pestovaný v skleníkoch 4 000 - pestovaný vonku 3 500 - od 1.IV.
Load more

Recommended publications
  • Commission Implementing Regulation (EU)
    21.3.2013 EN Official Journal of the European Union L 80/1 II (Non-legislative acts) REGULATIONS COMMISSION IMPLEMENTING REGULATION (EU) No 230/2013 of 14 March 2013 on the withdrawal from the market of certain feed additives belonging to the group of flavouring and appetising substances (Text with EEA relevance) THE EUROPEAN COMMISSION, submitted before that deadline for the only animal category for which those feed additives had been auth­ orised pursuant to Directive 70/524/EEC. Having regard to the Treaty on the Functioning of the European Union, (4) For transparency purposes, feed additives for which no applications for authorisation were submitted within the Having regard to Regulation (EC) No 1831/2003 of the period specified in Article 10(2) of Regulation (EC) No European Parliament and of the Council of 22 September 1831/2003 were listed in a separate part of the 2003 on additives for use in animal nutrition ( 1 ), and in Community Register of Feed Additives. particular Article 10(5) thereof, (5) Those feed additives should therefore be withdrawn from Whereas: the market as far as their use as flavouring and appetising substances is concerned, except for animal species and categories of animal species for which applications for (1) Regulation (EC) No 1831/2003 provides for the auth­ authorisation have been submitted. This measure does orisation of additives for use in animal nutrition and not interfere with the use of some of the abovemen­ for the grounds and procedures for granting such auth­ tioned additives according to other animal species or orisation. Article 10 of that Regulation provides for the categories of animal species or to other functional re-evaluation of additives authorised pursuant to Council groups for which they may be allowed.
    [Show full text]
  • Test Items for Licensing Examination Krok 1 PHARMACY
    MINISTRY OF PUBLIC HEALTH OF UKRAINE Department of human resources policy, education and science Testing Board Student ID Last name Variant ________________ Test items for licensing examination Krok 1 PHARMACY (російськомовний варіант) General Instruction Every one of these numbered questions or unfinished statements in this chapter corresponds to answers or statements endings. Choose the answer (finished statements) that fits best and fill in the circle with the corresponding Latin letter on the answer sheet. Authors of items: Abramov A.V., Aleksandrova K.V., Andronov D.Yu., Bilyk O.V., Blinder O.O., Bobyr V.V., Bobrovska O.A., Bohatyriova O.V., Bodnarchuk O.V., Boieva S.S., Bolokhovska T.O., Bondarenko Yu.I., Bratenko M.K., Buchko O.V., Cherneha H.V., Davydova N.V., Deriuhina L.I., Didenko N.O., Dmytriv A.M., Doroshkevych I.O., Dutka N.M., Dynnyk K.V., Filipova L.O., Havryliuk I.M., Herhel T.M., Hlushkova O.M., Hozhdzinsky S.M., Hrekova T.A., Hrechana O.V., Hruzevsky O.A., Hudyvok Ya.S., Hurmak I.S., Ivanets L.M., Ivanov Ye.I., Kartashova T.V., Kava T.V., Kazakova V.V., Kazmirchuk H.V., Kernychna I.Z., Khlus K.M., Khmelnykova L.I., Klebansky Ye.O., Klopotsky H.A., Klymniuk S.I., Kobylinska L.I., Koldunov V.V., Kolesnyk V.P., Kolesnikova T.O., Komlevoy O.M., Kononenko N.M., Kornijevsky Yu.Y., Kremenska L.V., Krushynska T.Yu., Kryzhanovska A.V., Kryshtal M.V., Kukurychkin Ye.R., Kuznietsova N.L., Kuzmina A.V., Lisnycha A.M., Lychko V.H., Makats Ye.F., Maly V.V., Matvijenko A.H., Menchuk K.M., Minarchenko V.M., Mikheiev A.O., Mishchenko
    [Show full text]
  • Subject: Manufacturing of Synthetic Organic Chemicals (API's: 400Kg
    Subject: Manufacturing of Synthetic Organic Chemicals (API’s: 400Kg/day + R&D: 33.3Kg/day) at Plot No. 4, Industrial Park, Attivaram Village, Ozili Mandal, SPSR Nellore District, Andhra Pradesh by M/s. Balaji Chirex Pvt. Ltd., - reg. Project proposal: M/s. Balaji Chirex Pvt. Ltd., proposed to establish a Synthetic Organic Chemical Manufacturing Unit at Plot No. 4, Industrial Park, Attivaram Village, Ozili Mandal, SPSR Nellore District, Andhra Pradesh. The company acquired 4.515 acres of land for the proposed plant and allocated 1.49 acres of the area for green belt. The site is surrounded by internal IDA road in north direction, Shimoga Life Sciences Pvt. Ltd., in east direction and open plots in south and west directions. The nearest human settlement from the site is Attivaram village located at distance of 1.1 km from the site. Mamidi Kalva is at a distance of 4.28 km in southwest direction, flowing from northeast to southwest. Attivaram RF at a distance of 0.5 Km in east, Jayampu RF at a distance of 7 Km in northwest, Permidi RF at a distance of 5 Km in southwest and Sangavaram RF at a distance of 4.5 Km in southwest directions respectively. There are no national parks or sanctuaries within 10 km radius of the site. Total capital cost of the project is Rs. 5 Crores. Manufacturing capacity is presented as follows; Manufacturing Capacity S.No Name of the Product Capacity Kg/Month Kg/Day 1 Alfuzosin 50 1.7 2 Allantion 200 6.7 3 Aripiprazole 100 3.3 4 Calcium Ascorbate 500 16.7 5 Calcium Aspartate 1000 33.3 6 Calcium Citrate Malate 2000
    [Show full text]
  • Oral Magnesium Gly Magnesium Glycerophosphate Ceroph
    pat hways Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate Evidence summary Published: 29 January 2013 nice.org.uk/guidance/esuom4 Key points from the evidence The content of this evidence summary was up-to-date in January 2013. See summaries of product characteristics (SPCs), British national formulary (BNF) or the MHRA or NICE websites for up-to-date information. Magnesium glycerophosphate is a magnesium salt that is available as a tablet, capsule, liquid solution or liquid suspension for oral use. The British national formulary (BNF) states that oral magnesium glycerophosphate is a suitable preparation to prevent recurrence of symptomatic hypomagnesaemia in people who have already been treated for this condition. This evidence summary looks at the use of oral magnesium glycerophosphate in patients who have previously been treated with an intravenous infusion of magnesium. Oral magnesium glycerophosphate does not have UK marketing authorisation for this or any other indication, and therefore it is an unlicensed medicine in the UK. No published clinical trials comparing the efficacy of oral magnesium glycerophosphate with placebo or any form of active treatment for preventing recurrent hypomagnesaemia after treatment with intravenous magnesium were identified. The only videncee found was from 3 case reports describing the use of oral magnesium glycerophosphate for preventing recurrent hypomagnesaemia in adults after intravenous treatment. © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- Page 1 of conditions#notice-of-rights). 17 Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4) Two of the 3 case reports concerned patients who had short bowel syndrome due to surgical resection.
    [Show full text]
  • 56 Subpart F—Flavoring Agents and Related Substances
    § 172.510 21 CFR Ch. I (4–1–12 Edition) needed to produce its intended effect (a) They are used in the minimum but not in excess of 13 parts per million quantity required to produce their in- calculated as anhydrous sodium ferro- tended physical or technical effect and cyanide. in accordance with all the principles of [42 FR 14491, Mar. 15, 1977, as amended at 58 good manufacturing practice. FR 17098, Apr. 1, 1993] (b) In the appropriate forms (plant parts, fluid and solid extracts, con- Subpart F—Flavoring Agents and centrates, absolutes, oils, gums, bal- Related Substances sams, resins, oleoresins, waxes, and dis- tillates) they consist of one or more of § 172.510 Natural flavoring substances the following, used alone or in com- and natural substances used in con- bination with flavoring substances and junction with flavors. adjuvants generally recognized as safe Natural flavoring substances and in food, previously sanctioned for such natural adjuvants may be safely used use, or regulated in any section of this in food in accordance with the fol- part. lowing conditions. Common name Scientific name Limitations Aloe ................................................................ Aloe perryi Baker, A. barbadensis Mill., A. ferox Mill., and hybrids of this sp. with A. africana Mill. and A. spicata Baker. Althea root and flowers .................................. Althea officinalis L. Amyris (West Indian sandalwood) ................. Amyris balsamifera L. Angola weed .................................................. Roccella fuciformis
    [Show full text]
  • Marketing Research on Dietary Supplements for Periodontitis in Patient Diabetes
    Original Study MARKETING RESEARCH ON DIETARY SUPPLEMENTS FOR PERIODONTITIS IN PATIENT DIABETES Galyna Biloklytska, Svitlana Viala, Alina Koval* National Medical Academy of Postgraduate Education named after P. L. Shupyk, Kyiv, Ukraine. ABSTRACT The vast majority of periodontal diseases are inflammatory and can develop under the influence of both local causes and the combined action of common (endogenous) and local factors against the background of changes in the reactivity of the body. In the pathogenesis of the development of periodontal diseases in patients with diabetes, the main role is given to angiopathies. Since periodontitis is characterized by various vascular disorders, which are largely similar to diabetic angiopathy, it is not easy to prove the presence of the latter with periodontitis. So some authors argue this, while, others deny it. The starting point of diabetic microangiopathies is a violation of carbohydrate metabolism, as well as a violation of glycosamine metabolism, which determines the functional and structural integrity of the vascular basement membrane. Key words: producing countries, periodontitis, diabetes mellitus, dietary supplements, medicines, dentistry. Introduction the treatment and prevention of such pathology, as periodontitis in patients with diabetes. Nowadays, the problem of treatment and rehabilitation of patients with periodontitis is quite actual, as there is an The search for modern drugs and perspective combinations increase in morbidity among people of working age, of microelements for treatment, both internally and locally, increasing demands on appearance as a factor that plays an using applications on periodontal tissues in patients with important role in professional and personal success in various types of diabetes, involves marketing analysis of society.
    [Show full text]
  • RIFM Fragrance Ingredient Safety Assessment, Menthyl Isovalerate CAS Registry Number 16409-46-4
    Food and Chemical Toxicology 110 (2017) S486eS495 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Short review RIFM fragrance ingredient safety assessment, menthyl isovalerate CAS Registry Number 16409-46-4 * A.M. Api a, , D. Belsito b, D. Botelho a, D. Browne a, M. Bruze c, G.A. Burton Jr. d, J. Buschmann e, M.L. Dagli f, M. Date a, W. Dekant g, C. Deodhar a, M. Francis a, A.D. Fryer h, K. Joshi a,S.LaCavaa, A. Lapczynski a, D.C. Liebler i, D. O'Brien a, R. Parakhia a,A.Patela, T.M. Penning j, G. Ritacco a, J. Romine a, D. Salvito a, T.W. Schultz k, I.G. Sipes l, Y. Thakkar a, E.H. Theophilus a, A.K. Tiethof a, Y. Tokura m, S. Tsang a, J. Wahler a a Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA b Member RIFM Expert Panel, Columbia University Medical Center, Department of Dermatology, 161 Fort Washington Ave., New York, NY 10032, USA c Member RIFM Expert Panel, Malmo University Hospital, Department of Occupational & Environmental Dermatology, Sodra Forstadsgatan 101, Entrance 47, Malmo SE-20502, Sweden d Member RIFM Expert Panel, School of Natural Resources & Environment, University of Michigan, Dana Building G110, 440 Church St., Ann Arbor, MI 58109, USA e Member RIFM Expert Panel, Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Strasse 1, 30625 Hannover, Germany f Member RIFM Expert Panel, University of Sao Paulo, School of Veterinary Medicine and Animal Science, Department of Pathology, Av.
    [Show full text]
  • MAGNESIUM and EHLERS-DANLOS SYNDROME PART ONE: *WHY* PERSONS with EDS NEED to KNOW ABOUT MAGNESIUM ©2013 Heidi Collins, MD
    MAGNESIUM AND EHLERS-DANLOS SYNDROME PART ONE: *WHY* PERSONS WITH EDS NEED TO KNOW ABOUT MAGNESIUM ©2013 Heidi Collins, MD Everybody should know about magnesium. It’s just that important. “Magnesium is needed for more than 300 biochemical reactions in the body. It helps maintain normal muscle and nerve function, keeps heart rhythm steady, supports a healthy immune system, and keeps bones strong. Magnesium also helps regulate blood sugar levels, promotes normal blood pressure, and is known to be involved in energy metabolism and protein synthesis.” – From Magnesium Fact Sheet from the National Institutes of Health (PLEASE TAKE THE TIME TO READ): http://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/ (Notice also the links provided at the bottom of the Fact Sheet to many of the 62 references.) What are some of the symptoms of magnesium deficiency? “Magnesium deficiency can affect virtually every organ system of the body. With regard to skeletal muscle, one may experience twitches, cramps, muscle tension, muscle soreness, including back aches, neck pain, tension headaches and jaw joint (or TMJ) dysfunction. Also, one may experience chest tightness or a peculiar sensation that he can't take a deep breath. Sometimes a person may sigh a lot. … Symptoms involving impaired contraction of smooth muscles include constipation; urinary spasms; menstrual cramps; difficulty swallowing or a lump in the throat-especially provoked by eating sugar; photophobia, especially difficulty adjusting to oncoming bright headlights in the absence of eye disease; and loud noise sensitivity from stapedius muscle tension in the ear. … The central nervous system is markedly affected. Symptoms include insomnia, anxiety, hyperactivity and restlessness with constant movement, panic attacks, agoraphobia, and premenstrual irritability.
    [Show full text]
  • (12) United States Patent (10) Patent N0.: US 7,265,155 B2 Artman Et A1
    US007265155B2 (12) United States Patent (10) Patent N0.: US 7,265,155 B2 Artman et a1. (45) Date of Patent: *Sep. 4, 2007 (54) TREATING A VARIETY OF PATHOLOGICAL W0 98 08498 A 3/1998 CONDITIONS, INCLUDING SPASTICITY WO WO98/08498 3/1998 AND CONVULSIONS, BY EFFECTING A WO WO99/44623 3/1999 MODULATION OF CNS ACTIVITY WITH W0 WO 01/28516 10/2000 ISOVALERAMIDE, ISOVALERIC ACID, OR A RELATED COMPOUND OTHER PUBLICATIONS Schon and Blau, J Neurol Neurosurg Psychiatry, Sep. 1987: (75) Inventors: Linda D. Artman, Salt Lake City, UT 50(9):1148-1152.* (US); Manuel Balandrin, Sandy, UT Dorland’s Medical Dictionary 27th ed. p. 379* (US); Robert L. Smith, Lansdale, PA Pharmacotherapy, A Pathophysiologic Approach, Dipiro et al.2nd (Us) ed. 1991, pp. 1232, 1238).* Drug facts and comparisons 1999 ed. pp. 1595-1597(“Drug (73) Assignee: NBS Pharmaceuticals, Inc., Salt Lake Facts”).* City, UT (US) Pharmacotherapy, A Pathophysiologic Approach, Dipiro et al. 2nd ed. 1991, pp. 1232 & 1238* Notice: Subject to any disclaimer, the term of this Drug Facts and Comparisons. 1999 ed. pp. 1595-1597 (“Drug patent is extended or adjusted under 35 Facts”).* Julius A. Vida “Advances in Anticonvulsant Drug Development”; USC 154(b) by 0 days. Anticonvulsants (1997) pp. 1-9; Academic Press. Julius A. Vida “Noncyclic Anticonvulsants”; Anticonvulsants This patent is subject to a terminal dis (1977) pp. 577-619; Academic Press. claimer. Salim Hadad, et al. “Pharmacokinetic Analysis and Antiepileptic Activity of N-Valproyl Deriatives of GABA and Glycine”; Phar (21) Appl. N0.: 10/614,344 maceutical Research (1995), pp. 905-907; Plenum Publishing Cor poration.
    [Show full text]
  • Cigarette Additives, Carcinogens and Chemicals Nicotine
    Cigarette Additives, Carcinogens and Chemicals Nicotine A Destructive Natural Pesticide Which ... Is extremely addictive when smoked Is extremely addictive when chewed Causes addiction as permanent as Is harder to quit than heroin or cocaine alcoholism Is not medicine and its use not therapy Is ineffective as a stand-alone quitting aid Prevents pre-cancerous cells from dying Accelerates cancer tumor growth rates Contributes to artery hardening Has a metabolite which may cause cancer May kill brain cells and impair memory Is linked to lung cancer Likely causes brain damage and Is also a fetus destroying teratogen depression Kills half of adult smokers 13-14 years Is beat by never taking another puff or early chew! 81 Cancer Causing Chemicals Have So Far Been Identified in Cigarettes Acetaldehyde Acetamide Acrylamide Acrylonitrile 2-Amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (MeIQ) 3-Amino-1,4-dimethyl-5H-pyrido [4,3-b]indole (Trp-P-1) 2-Amino-l-methyl-6-phenyl-1H-imidazo [4,5-b]pyridine (PhlP) 2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) 3-Amino-l-methyl-5H-pyrido {4,3-b]indole (Trp-P-2 2-Amino-3-methyl-9H-pyrido[2,3-b]indole (MeAaC) 2-Amino-9H-pyrido[2,3-b]indole (AaC) 4-Aminobiphenyl 2-Aminodipyrido[1,2-a:3',2'-d]imidazole (Glu-P-2) 0-Anisidine Arsenic Benz[a]anthracene Benzene Benzo[a]pyrene Benzo[b]fluoranthene Benzo[j]fluoranthene Benzo[k]fluoranthene Benzo[b]furan Beryllium 1,3-Butadiene Cadmium Catechol (1,2-benzenediol) p-Chloroaniline Chloroform Cobalt p,p'-DDT Dibenz[a,h]acridine Dibenz[a,j]acridine Dibenz(a,h)anthracene
    [Show full text]
  • Nucleosides, Nucleotides, Heterocyclic Compounds, Pyridine 2013
    Nucleosides, Nucleotides, Heterocyclic Compounds, Pyridine, Pyrimidine, Azaindole, Quinoline, Thiazole, Isatin, Phenanthrene, Thiophene We declare that some of the listed products might be protected by valid patents. They are only for scientific research and development purpose. They are not offered for sales in countries where the sales of such products constitutes patents infringement. The liability for patents checking and patents infringement is exclusive at buyers risk! I2CNS LLC CANNOT BE HELD LIABLE FOR ANY VIOLATIONS OF PATENT RIGHTS CAUSED BY CUSTOMERS. CAS No. Product Name and Description 26988-72-7 1-METHYL-DL-TRYPTOPHAN 68886-07-7 2-Fluoro-4-hydroxyphenylaceticacid 72607-53-5 N-(3-AMINOPROPYL)METHACRYLAMIDE 171049-41-5 7-AMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLICACIDTERT- BUTYLESTER 885280-38-6 (3-OXO-CYCLOHEXYL)-CARBAMICACIDTERT-BUTYLESTER 186826-86-8 MOXIFLOXACIN HCL 102735-53-5 L-CYCLOPROPYLALANINE 145100-50-1 2-[N,N-BIS(TRIFLUOROMETHYLSULFONYL)AMINO]PYRIDINE 143491-57-0 Emtricitabine 39809-25-1 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3,9-dihydropurin-6-one 147127-20-6 Tenofovir 716-39-2 2,3-NAPHTHALENEDICARBOXYLICANHYDRIDE 4333-62-4 1,3-DIMETHYLIMIDAZOLIUMIODIDE 108-45-2 m-Phenylenediamine 1961-72-4 R-(3)-HYDROXYMYRISTICACID 131-48-6 N-Acetylneuraminicacid 88196-70-7 (R)-1-(3-Methoxyphenyl)ethylamine 680-31-9 Hexamethylphosphoramide 486-66-8 Daidzein 872-50-4 1-Methyl-2-pyrrolidinone 425378-68-3 2-FLUORO-5-NITROPHENYLBORONICACIDPINACOLESTER 115651-29-1 5-ACETYL-2-AMINO-4-HYDROXYBENZOICACID 115269-99-3 N,N-BIS-BOC-N-ALLYLAMINE
    [Show full text]
  • CHELATED MINERALS Addressing Key Challenges in Mineral Supplementation
    NATURAL MEDICINE JOURNAL RESEARCH GUIDE SPONSORED BY ALBION MINERALS CHELATED MINERALS Addressing Key Challenges in Mineral Supplementation Author: Sarah Cook, ND © 2018 IMPACT Health Media, Inc. All rights reserved. This publication may not be reproduced or distributed in any form without written permission from IMPACT Health Media, Inc. Minerals affect nearly all physiologic functions in the human body. Minerals are necessary cofactors for hun- Industrial agricultural practices, food dreds of biochemical reactions as well as essential for nerve conduction, muscle contraction, bone strength, processing, chronic stress, over-exercise, immune function, energy production, and oxygen trans- and poor dietary choices increase the risk of port to name a few. Mineral status influences metabolic mineral deficiencies health, cardiovascular health, prostate health, reproduc- tive health, cognition, and more. Although the human body tightly regulates the avail- ability of minerals and has mechanisms to store them for later use, minerals cannot be endogenously produced. To fulfill the ongoing requirements of the body, people must regularly consume the essential minerals (table 1) from exogenous sources. Table 1. Essential Minerals* Macro- Trace Ultratrace minerals Minerals Minerals Calcium Copper Chromium of people worldwide have inadequate zinc intake. Insuf- Chloride Iron Molybdenum ficiencies in these minerals can contribute to anemia, Magnesium Zinc Vanadium mood disorders, infertility, and more. Potassium Fluoride Iodine Sodium Manganese Selenium Supplementation is sometimes the best or only way Phosphorus Boron to correct mineral deficiencies and to achieve optimal physiologic levels. Choosing the best supplement, * Macrominerals are present in large amounts in the however, can be complicated. This research guide raises body, trace minerals are present in small amounts, and 3 key challenges posed by mineral supplementation and ultratrace minerals are consumed in less than 1 mg/day.
    [Show full text]